SeaStar Medical director granted 4,000 RSUs
Neuman John reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Neuman John reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp director John Neuman received an equity award of 4,000 shares of common stock in the form of restricted stock units (RSUs). The award was granted at a price of $0.00 per share as compensation, not as an open-market purchase.
The RSUs will vest in full on July 1, 2027, meaning Neuman must remain eligible through that date to receive the underlying shares. Following this grant, he holds 16,200 shares of SeaStar Medical common stock in total as reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.0001 | 4,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027.
Key Figures
Key Terms
restricted stock unit financial
RSU financial
vest financial
grant/award acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SeaStar Medical (ICU) director John Neuman report in this Form 4?
Is the SeaStar Medical (ICU) Form 4 transaction a market purchase or a compensation grant?
When do John Neuman’s 4,000 RSUs from SeaStar Medical (ICU) vest?
What does transaction code "A" mean in the SeaStar Medical (ICU) Form 4?
Does the SeaStar Medical (ICU) Form 4 show any insider sales by John Neuman?
AI-generated analysis. How Rhea-AI works. Not financial advice.